LNSR

LENSAR Inc.

Price

$6.25

return (12m)

-47.43%

p/e

2.28

p/bv

5.31

DIVIDEND YIELD

0.00%

LNSR price

LENSAR

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LNSR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-21.19%

3 months

8.51%

1 year

-47.43%

2 years

29.40%

5 years

-16.67%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LNSR

Valuation

P/E

2.28

Sector 1.07

Industry 3.44

P/BV

5.31

Sector 1.86

Industry 2.12

P/Revenue (PSR)

1.31

Sector 1.54

Industry 1.69

EV/EBITDA

20.26

Sector -45.27

Industry 1.81

EV/EBIT

30.75

Sector -48.49

Industry -3.96

P/EBITDA

-22.27

Sector -31.51

Industry -53.51

P/EBIT

-9.75

Sector -42.93

Industry -50.81

P/Total Assets

1.14

Sector 0.85

Industry 0.94

P/Net Current Assets

12.86

Sector -25.71

Industry -10.60

P/Working Capital

2.89

Sector -4.14

Industry 2.66

EPS

2.82

Sector -0.70

Industry -0.60

BVPS

1.21

Sector 4.52

Industry 4.74

Efficiency

Gross Margin

48.34%

Sector 49.51%

Industry 50.68%

EBITDA Margin

19.64%

Sector -280.81%

Industry -57.47%

EBIT Margin

-13.48%

Sector -19.82%

Industry -25.80%

Net Profit Margins

57.57%

Sector -24.01%

Industry -29.17%

Asset Turnover

0.24

Sector 0.13

Industry 0.15

Profitability

ROE

232.78%

Sector -23.78%

Industry -22.30%

ROA

49.88%

Sector -24.20%

Industry -24.15%

ROIC

20.26%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.39

Sector 1.91

Industry 1.98

Net Debt / EBITDA

-4.19

Sector -23.21

Industry -2.21

Net Debt / EBIT

-6.36

Sector -17.93

Industry -1.50

Net Debt / Equity

-0.91

Sector -0.68

Industry -0.29

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.82

Equity/Assets

0.21

Sector 0.46

Industry 0.47

Liabilities/Assets

0.59

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

11.83%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals LNSR

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF LENSAR ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$6.25

Fair Value

$8.76

Upside

40.19%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LNSR LENSAR Inc.	$6.25	-47.43%	0.00%	2.28	5.31	232.78%	57.57%
ABT Abbott Laboratories	$102.20	-19.92%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.07	0.39%	3.28%	21.29	2.19	10.29%	13.93%
BSX Boston Scientific Corp.	$43.13	-54.80%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.38	-26.01%	0.00%	18.01	5.27	29.28%	22.69%
RMD ResMed Inc.	$234.61	-12.84%	1.07%	21.81	5.05	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$521.27	-15.40%	0.00%	35.95	25.41	70.67%	25.03%
COHR Coherent Inc.	$283.44	155.12%	0.00%	74.48	5.34	7.16%	11.31%
SYK Stryker Corp.	$281.76	-21.68%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.82	-5.61%	4.20%	17.81	1.74	9.80%	6.30%
INMD InMode Ltd.	$14.33	-6.13%	0.00%	10.78	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$187.39	2.94%	2.30%	53.38	2.06	3.85%	6.29%
DXCM DexCom Inc.	$85.21	30.85%	0.00%	32.03	12.21	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.60	15.77%	0.00%	47.85	4.48	9.37%	15.43%
ALGN Align Technology Inc.	$141.41	12.41%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.86	-17.87%	2.88%	20.20	4.39	21.74%	9.20%
IRMD iRadimed Corporation	$89.76	26.66%	1.46%	48.20	10.92	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$92.30	-1.26%	1.08%	21.13	1.35	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LNSR - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT LENSAR

LENSAR Inc.

Average Investor10 user rating

4.0 (1 people)

United States

22 years

Founded: 2004

2020

Time since IPO - 6 years

100

Employees

LENSAR Inc. (United States) is listed on the Nasdaq and has a market capitalization of $79.19 million, with shareholders equity totaling $14.91 million.

The company employs approximately 100 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, LENSAR Inc. reported $60.26 million in revenue, generating net income of $34.70 million.

Key financial metrics include a P/E ratio of 2.28, a price-to-book (P/B) ratio of 5.31, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LNSR.

Market cap

$79.19 million

Net worth

$14.91 million

$14,905,000.00

Assets

$69.56 million

$69,558,000.00

Total Shares Outstanding

12.30 million

12,297,000

Average Daily Trading Volume

$122.48 Thousand

$122,484.42

Sector

Health

Industry

Medical Supplies and Equipment

LNSR

LNSR revenue and profits

Financial Results LNSR

DRAG THE FRAME TO SEE MORE DATA

LNSR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.73 16,27% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$283.40 --1,90% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$69.20 90,32% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$424.68 59,34% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$39.43 --16,02% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$246.60 32,11% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,168.32 43,48% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$460.26 12,61% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74